Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1858 1
1916 2
1917 1
1919 1
1920 2
1927 1
1931 1
1950 2
1951 1
1952 1
1959 1
1962 1
1967 1
1968 1
1969 1
1970 1
1971 2
1972 4
1973 6
1974 6
1975 2
1976 1
1977 4
1979 5
1980 5
1983 5
1984 3
1985 1
1986 2
1987 5
1988 2
1989 1
1991 4
1992 4
1993 4
1994 8
1995 3
1996 9
1998 6
1999 3
2000 7
2001 8
2002 2
2003 1
2004 3
2005 8
2006 11
2007 10
2008 4
2009 6
2010 5
2011 7
2012 10
2013 9
2014 12
2015 14
2016 9
2017 16
2018 15
2019 10
2020 11
2021 9
2022 11
2023 11
2024 4
2025 6
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

320 results

Results by year

Filters applied: . Clear all
Page 1
Safety and immunogenicity of mRNA-based mpox vaccine candidate BNT166a: an open-label, dose-escalation, first-in-human trial.
Bähner F, Faust SN, Davies LRL, Blokhina O, Brandon DM, Smith WB, Chatterjee VKK, Hassanin H, Babu TM, Zuiani A, Steinhauser S, Poran A, Brittain C, Mucker E, Hooper JW, van der Most RG, Alonso PL, Türeci Ö, Mensa FJ, Şahin U. Bähner F, et al. Among authors: smith wb. Lancet Infect Dis. 2026 Jun 3:S1473-3099(26)00177-5. doi: 10.1016/S1473-3099(26)00177-5. Online ahead of print. Lancet Infect Dis. 2026. PMID: 42235570
Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years.
Mitha E, Ferguson M, Wilhase AC, De Looze F, Vachon ML, Stacey H, Rasalam R, Nozaki M, Smith WB, Schwarz TF, Hailemariam HA, Deraedt Q, Gérard C, Vanden Abeele C, Damaso S, Descamps D, Hill J, Dasyam D, Van Gucht J, Hulstrøm V. Mitha E, et al. Among authors: smith wb. Clin Infect Dis. 2026 May 20;82(5):e1093-e1103. doi: 10.1093/cid/ciag058. Clin Infect Dis. 2026. PMID: 41757519 Free PMC article. Clinical Trial.
A Phase 2b Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 6-Valent Group B Streptococcus Vaccine Administered Concomitantly With Tetanus, Diphtheria, and Acellular Pertussis Vaccine in Healthy Nonpregnant Female Individuals.
Smith WB, Seger W, Chawana R, Skogeby Z, Silmon de Monerri NC, Feng Y, Gaylord M, Jongihlati B, Beeslaar J, Skinner JM, Bickham K, Anderson AS. Smith WB, et al. J Infect Dis. 2025 Jul 11;231(6):e1065-e1074. doi: 10.1093/infdis/jiaf096. J Infect Dis. 2025. PMID: 40036340 Free PMC article. Clinical Trial.
A Growth Differentiation Factor 15 Receptor Agonist in Randomized Placebo-Controlled Trials in Healthy or Obese Persons.
Smith WB, Nguyen D, Clough T, Schofield J, Kagan MR, Kompa J, He Y, Maratos-Flier E, Jamontt J, Vong L, Schwartzkopf CD, Layne JD, Usera AR, O'Donnell CJ, Heldwein KA, Streeper RS, Goldfine AB. Smith WB, et al. J Clin Endocrinol Metab. 2025 Feb 18;110(3):771-786. doi: 10.1210/clinem/dgae550. J Clin Endocrinol Metab. 2025. PMID: 39148430 Free article. Clinical Trial.
320 results